PAVM: PAVmed Forward P/E Multiple

Graphic logo of PAVmed (PAVM)

The stability of PAVmed Inc. (PAVM) is underpinned by the automation of biodata collection, as evidenced by this chart provided by the GURU.Markets system, where the company's forward P/E metric records a level of 0.00. The operational base relies on the profitable licensing of unique developments and a flawless brand image among physicians, guaranteeing the high reliability of the company's engineering solutions.

Price to Future Earnings Ratio: PAVmed Inc. (PAVM) for 07/04/2022 - 11/13/2026

Summary analytical data breakdowns for PAVmed Inc (PAVM)

- stock value and consensus price forecast:
Price Chart PAVmed Inc.|PAVM - Price Target Chart
- market capitalization information:
Market Capitalization PAVmed, Inc.|PAVM - Enterprise Value
- book capitalization information:
Net Assets per Single Share PAVmed|PAVM - Accounting Capitalization|Market Capitalization to Book Value Ratio pavmed.com|PAVM - Company Assets
- company liabilities and liquidity data:
Debt to Equity PAVmed Inc.|PAVM - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio PAVmed Inc.|PAVM - Company Aggregate Debts|Debt to Book Capitalization Ratio PAVmed, Inc.|PAVM - Long-Term Debt Volume|Company Current Liabilities PAVmed|Quick Liquidity pavmed.com
- company profitability and valuation multiples indicators:
PAVM - Net Income|Projected Future Earnings PAVmed Inc.|PAVM - Market Cap to Earnings|Forward P/E Multiple PAVmed Inc.|PAVM - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple PAVmed, Inc.|PAVM - Operating income before deduction of amortization|Net earnings per share (EPS TTM) PAVmed|PAVM - Net earnings per share for the last 12 months|Quarterly EPS earnings growth pavmed.com|PAVM - Earnings growth in current year|Net earnings per share growth forecast for next year PAVmed Inc.
Comprehensive company analysis:PAVM PAVmed
Signature product of pavmed.com

The forward P/E ratio compares the current market value of a share with the expected net income for the following year, measuring investors' willingness to pay a premium for future growth. By analyzing the forward P/E chart for PAVmed Inc. (PAVM), one can assess the risk of a correction if commercialization goals for EsoGuard and CarpX are not met, as a high valuation reflects the technological potential of the medical incubator PAVmed Inc. (PAVM).

Main competitors

Future Price to Earnings Stryker (SYK)|Future Price to Earnings MDT (Medtronic Inc.)|Forward P/E Multiple PHG (Koninklijke Philips NV)|Forward P/E Multiple Smith+Nephew SNN|HOLX - Future Price to Earnings|CSL (carlisle.com) - Price to Future Earnings Ratio|ITGR: Forward P/E Multiple|Projected Price to Earnings Ratio LivaNova plc (LIVN)|Future Price to Earnings AdaptHealth LLC|Projected Price to Earnings Ratio ssinnovations.com SSII|Projected Price to Earnings AVNS (Avanos Medical, Inc.)|Forward P/E Multiple shoulderinnovations.com (SI)|Future Price to Earnings Viemed VMD|Market Cap to Projected Earnings Inogen Inc (INGN)|OWLT: Projected Price to Earnings|Future Price to Earnings Multiple QIPT (Quipt)|poci.com (POCI) - Future Price to Earnings|Projected Price to Earnings tivichealth.com|MOVE (Movano) - Forward P/E Multiple|Projected Price to Earnings Ratio Holdco Nuvo Group NUVO